Correlation of tumor necrosis factor alpha levels with disease activity of rheumatoid arthritis
- PMID: 1342640
Correlation of tumor necrosis factor alpha levels with disease activity of rheumatoid arthritis
Abstract
In this study, positive correlations were found between tumor necrosis factor alpha (TNF alpha) levels in the sera of rheumatoid arthritis (RA) patients and the duration of morning stiffness, joint tenderness count, the Ritchie articular index and erythrocyte sedimentation rate. Further, higher mean grades of disease activity of RA were accompanied by correspondingly higher levels of serum and synovial TNF alpha. In the longitudinal study, when the disease activity of RA decreased after treatment, serum TNF alpha levels also decreased. This suggests that the levels of serum and synovial TNF alpha correlate positively with RA disease activity. The levels of TNF alpha in synovial fluid were significantly higher in RA and acute gouty arthritis (GA) patients than in osteoarthritis (OA) patients. This suggests that joint inflammation in inflammatory arthritis related to local production of TNF alpha in the joint cavities. Serum TNF alpha levels in RA patients were significantly higher than those in the OA patients; no statistical difference was found between acute GA and OA patients.
Similar articles
-
Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.J Rheumatol. 1995 Mar;22(3):406-12. J Rheumatol. 1995. PMID: 7783054
-
Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.Ital J Biochem. 2005 Sep-Dec;54(3-4):248-57. Ital J Biochem. 2005. PMID: 16688934
-
Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.Arthritis Rheum. 2000 Feb;43(2):281-8. doi: 10.1002/1529-0131(200002)43:2<281::AID-ANR7>3.0.CO;2-7. Arthritis Rheum. 2000. PMID: 10693867
-
Acute-phase proteins in osteoarthritis.Semin Arthritis Rheum. 1995 Oct;25(2):75-86. doi: 10.1016/s0049-0172(95)80020-4. Semin Arthritis Rheum. 1995. PMID: 8578314 Review.
-
TNF alpha--a pivotal role in rheumatoid arthritis?Br J Rheumatol. 1992 May;31(5):293-8. doi: 10.1093/rheumatology/31.5.293. Br J Rheumatol. 1992. PMID: 1581770 Review.
Cited by
-
Denosumab: targeting the RANKL pathway to treat rheumatoid arthritis.Expert Opin Biol Ther. 2017 Jan;17(1):119-128. doi: 10.1080/14712598.2017.1263614. Epub 2016 Nov 30. Expert Opin Biol Ther. 2017. PMID: 27871200 Free PMC article. Review.
-
Calotropis procera latex extract affords protection against inflammation and oxidative stress in Freund's complete adjuvant-induced monoarthritis in rats.Mediators Inflamm. 2007;2007:47523. doi: 10.1155/2007/47523. Epub 2007 Mar 19. Mediators Inflamm. 2007. PMID: 17497032 Free PMC article.
-
Role of Secreted Frizzled-Related Protein 1 and Tumor Necrosis Factor-α (TNF-α) in Bone Loss of Patients with Rheumatoid Arthritis.Int J Rheumatol. 2020 Mar 1;2020:9149762. doi: 10.1155/2020/9149762. eCollection 2020. Int J Rheumatol. 2020. PMID: 32190056 Free PMC article.
-
Serum Tumor Necrosis Factor-Alpha as a Competent Biomarker for Evaluation of Disease Activity in Early Rheumatoid Arthritis.Cureus. 2021 May 29;13(5):e15314. doi: 10.7759/cureus.15314. Cureus. 2021. PMID: 34221763 Free PMC article.
-
Potential applicability of cytokines as biomarkers of disease activity in rheumatoid arthritis: Enzyme-linked immunosorbent spot assay-based evaluation of TNF-α, IL-1β, IL-10 and IL-17A.PLoS One. 2021 Jan 26;16(1):e0246111. doi: 10.1371/journal.pone.0246111. eCollection 2021. PLoS One. 2021. PMID: 33497394 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical